Theraclion SA (ALTHE.PA)
EUR 0.36
(-2.72%)
EUR 0.36
(-2.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.67 Million EUR | 25.97% |
| 2022 | -4.96 Million EUR | -32.03% |
| 2021 | -3.76 Million EUR | 3.71% |
| 2020 | -3.9 Million EUR | -2.98% |
| 2019 | -3.79 Million EUR | 38.29% |
| 2018 | -6.14 Million EUR | 1.28% |
| 2017 | -6.22 Million EUR | 4.77% |
| 2016 | -6.53 Million EUR | -1.92% |
| 2015 | -6.41 Million EUR | -38.38% |
| 2014 | -4.63 Million EUR | -12.73% |
| 2013 | -4.11 Million EUR | -33.78% |
| 2012 | -3.07 Million EUR | -83.44% |
| 2011 | -1.67 Million EUR | 12.53% |
| 2010 | -1.91 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.36 Million EUR | 0.0% |
| 2023 Q2 | -2.47 Million EUR | 0.0% |
| 2023 Q4 | -1.19 Million EUR | 0.0% |
| 2023 FY | -3.67 Million EUR | 25.97% |
| 2022 Q2 | -2.56 Million EUR | 0.0% |
| 2022 FY | -4.96 Million EUR | -32.03% |
| 2022 Q4 | -2.4 Million EUR | 0.0% |
| 2021 FY | -3.76 Million EUR | 3.71% |
| 2021 Q2 | -1.63 Million EUR | 0.0% |
| 2021 Q4 | -2.12 Million EUR | 0.0% |
| 2020 Q2 | -1.87 Million EUR | 0.0% |
| 2020 Q4 | -2.03 Million EUR | 0.0% |
| 2020 FY | -3.9 Million EUR | -2.98% |
| 2019 Q2 | -1.67 Million EUR | 0.0% |
| 2019 Q4 | -2.11 Million EUR | 0.0% |
| 2019 FY | -3.79 Million EUR | 38.29% |
| 2018 Q4 | -2.53 Million EUR | 0.0% |
| 2018 Q2 | -3.61 Million EUR | 0.0% |
| 2018 FY | -6.14 Million EUR | 1.28% |
| 2017 Q2 | -3.4 Million EUR | 0.0% |
| 2017 Q4 | -2.82 Million EUR | 0.0% |
| 2017 FY | -6.22 Million EUR | 4.77% |
| 2016 Q4 | -3.04 Million EUR | 0.0% |
| 2016 FY | -6.53 Million EUR | -1.92% |
| 2016 Q2 | -3.49 Million EUR | 0.0% |
| 2015 Q2 | -3.17 Million EUR | 0.0% |
| 2015 Q4 | -3.23 Million EUR | 0.0% |
| 2015 FY | -6.41 Million EUR | -38.38% |
| 2014 FY | -4.63 Million EUR | -12.73% |
| 2014 Q4 | -2.35 Million EUR | 0.0% |
| 2014 Q2 | -2.28 Million EUR | 0.0% |
| 2013 Q3 | -1.02 Million EUR | 48.54% |
| 2013 Q4 | -2.11 Million EUR | -105.67% |
| 2013 FY | -4.11 Million EUR | -33.78% |
| 2013 Q2 | -1.99 Million EUR | 0.0% |
| 2012 FY | -3.07 Million EUR | -83.44% |
| 2012 Q4 | -1.02 Million EUR | -33.78% |
| 2012 Q1 | -768.18 Thousand EUR | 0.0% |
| 2012 Q2 | -768.18 Thousand EUR | 0.0% |
| 2012 Q3 | -768.18 Thousand EUR | 0.0% |
| 2011 Q3 | -418.75 Thousand EUR | 0.0% |
| 2011 FY | -1.67 Million EUR | 12.53% |
| 2011 Q1 | -418.75 Thousand EUR | 0.0% |
| 2011 Q2 | -418.75 Thousand EUR | 0.0% |
| 2011 Q4 | -768.18 Thousand EUR | -83.44% |
| 2010 Q3 | -478.74 Thousand EUR | 0.0% |
| 2010 Q2 | -478.74 Thousand EUR | 0.0% |
| 2010 Q1 | -478.74 Thousand EUR | 0.0% |
| 2010 FY | -1.91 Million EUR | 0.0% |
| 2010 Q4 | -418.75 Thousand EUR | 12.53% |
| 2009 Q4 | -478.74 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | 76.522% |
| Bluelinea Société Anonyme | -1.62 Million EUR | -126.852% |
| Carmat SA | -53.86 Million EUR | 93.178% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | 25.697% |
| Euromedis Groupe | 13.11 Million EUR | 128.031% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | 176.008% |
| Ikonisys S.A. | -2.26 Million EUR | -62.063% |
| Implanet S.A. | -6.67 Million EUR | 44.952% |
| Median Technologies SA | -22.98 Million EUR | 84.009% |
| SpineGuard SA | -4.18 Million EUR | 12.153% |
| Euroapi S.A. | -189.7 Million EUR | 98.063% |
| Guerbet SA | 23.86 Million EUR | 115.398% |
| Ion Beam Applications SA | -9.11 Million EUR | 59.66% |
| Koninklijke Philips N.V. | -466 Million EUR | 99.211% |
| Sequana Medical NV | -32.56 Million EUR | 88.714% |